Download PDF
CC BY-NC-ND 4.0 · J Lab Physicians 2019; 11(01): 058-062
DOI: 10.4103/JLP.JLP_106_18
Original Article

Evaluation of various risk factors associated with multidrug-resistant organisms isolated from diabetic foot ulcer patients

Priya Datta
Department of Microbiology, Government Medical College and Hospital, Chandigarh, India
,
Jagdish Chander
Department of Microbiology, Government Medical College and Hospital, Chandigarh, India
,
Varsha Gupta
Department of Microbiology, Government Medical College and Hospital, Chandigarh, India
,
Gursimran Kaur Mohi
Department of Microbiology, Government Medical College and Hospital, Chandigarh, India
,
Ashok K. Attri
Department of Surgery, Government Medical College and Hospital, Chandigarh, India
› Author Affiliations Financial support and sponsorship: This study was supported by the Department of Science and Technology, Chandigarh, India.
› Further Information
Also available at
  PDF Download Permissions and Reprints

Abstract

AIMS: Diabetic foot ulcer is a dreaded complication of diabetes. Diabetic foot ulcer patients are often infected with multidrug resistant organism (MDRO) due to chronic course of the wound, inappropriate antibiotics treatment, frequent hospital admission, neuropathy, nephropathy, and peripheral vascular disease.

MATERIALS AND METHODS: This prospective study was conducted in our 750 bedded hospital for a period of 6 months. The present study was undertaken to isolate various MDRO methicillin resistant Staphylococcus aureus; Gram-negative bacteria producing enzymes such as extended spectrum beta-lactamases (ESBL), Amp C, Carbapenamases; Pseudomonas and Acinetobacter species producing metallo-beta-lactamases (MBL). In addition we attempted to identify risk factors for association of diabetic foot ulcer and MDRO.

RESULTS: A total of 149 bacterial isolates were identified. Of the total isolates 73.2% were Gram-negative and remaining 26.8% were Gram-positive bacteria. Among Enterobacteriaceae 59% were ESBL producers and 48% were Amp C producers. In addition, 41.5% of the isolates produced both ESBL and Amp C and 13.4% were carbapenem resistant Enterobacteriaceae. Among 20 Pseudomonas and Acinetobacter isolates, 5 were MBL producers (25%). Furthermore, in the study, 56% of patients with diabetic foot ulcer harbored MDRO. The risk of multidrug-resistant infection is significantly more in patients having diabetes duration >20 years and size of ulcer more than 4 cm2.

CONCLUSION: The detection of MDRO in patients of diabetic foot ulcer changes the treatment strategies limits the antimicrobial options and causes higher complications among them.

Key words

Diabetic foot ulcer - multidrug resistant organisms - risk factors


Publication History

Received: 06 August 2018

Accepted: 11 January 2019

Article published online:
06 April 2020

© 2019.

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • References

  • 1 Viswanathan V, Jasmine JJ, Snehalatha C, Ramachandran A. Prevalence of pathogens in diabetic foot infection in South Indian type 2 diabetic patients. J Assoc Physicians India 2002;50:1013-6.
  • 2 Kandemir O, Akbay E, Sahin E, Milcan A, Gen R. Risk factors for infection of the diabetic foot with multi-antibiotic resistant microorganisms. J Infect 2007;54:439-45.
  • 3 Gadepalli R, Dhawan B, Sreenivas V, Kapil A, Ammini AC, Chaudhry R, et al. Aclinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital. Diabetes Care 2006;29:1727-32.
  • 4 Lavery LA, Armstrong DG, Wunderlich RP, Mohler MJ, Wendel CS, Lipsky BA, et al. Risk factors for foot infections in individuals with diabetes. Diabetes Care 2006;29:1288-93.
  • 5 Collee JG, Miles RS, Watt B. Tests for the identification of bacteria. In: Collee JG, Fraser AG, Marmion BP, Simmons A, editors. Mackie & McCartney Practical Medical Microbiology. 14th ed. London: Churchill Livingstone; 1996. p. 151-79.
  • 6 Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty First Informational Supplement M100-S21. Wayne, PA, USA: Clinical and Laboratory Standards Institute; 2016.
  • 7 Black JA, Moland ES, Thomson KS. AmpC disk test for detection of plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae lacking chromosomal AmpC beta-lactamases. J Clin Microbiol 2005;43:3110-3.
  • 8 Galani I, Rekatsina PD, Hatzaki D, Plachouras D, Souli M, Giamarellou H, et al. Evaluation of different laboratory tests for the detection of metallo-beta-lactamase production in Enterobacteriaceae. J Antimicrob Chemother 2008;61:548-53.
  • 9 Jog AS, Shadija PG, Ghosh SJ. Detection of multidrug resistant Gram-negative bacilli in type II diabetic foot infection. Int J Med Sci 2013;2:186-99.
  • 10 Hartemann-Heurtier A, Robert J, Jacqueminet S, Ha Van G, Golmard JL, Jarlier V, et al. Diabetic foot ulcer and multidrug-resistant organisms: Risk factors and impact. Diabet Med 2004;21:710-5.
  • 11 Rawat V, Singhai M, Kumar A, Jha PK, Goyal R. Bacteriological and resistance profile in isolates from diabetic patients. N Am J Med Sci 2012;4:563-8.
  • 12 Datta P, Gupta V, Arora S, Garg S, Chander J. Epidemiology of ESL, Amp C and Carbapenamases producing Proteus mirabilis. Jpn J Infect Dis 2014;67:44-6.
  • 13 Gupta V, Datta P, Agnihotri N, Chander J. Comparative in vitro activities of seven new beta-lactams, alone and in combination with beta-lactamase inhibitors, against clinical isolates resistant to third generation cephalosporins. Braz J Infect Dis 2006;10:22-5.
  • 14 Richard JL, Sotto A, Jourdan N, Combescure C, Vannereau D, Rodier M, et al. Risk factors and healing impact of multidrug-resistant bacteria in diabetic foot ulcers. Diabetes Metab 2008;34:363-9.